dersalazine (UR 12746) / Uriach Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dersalazine (UR 12746) / Uriach Pharma
NCT00808977 / 2008-004610-27: A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

Completed
2
80
Europe
Dersalazine sodium, Mesalazine, Placebo
Palau Pharma S.A.
Ulcerative Colitis
06/10
06/10

Download Options